Search by Drug Name or NDC

    NDC 70436-0212-54 gadobutrol 604.72 mg/mL Details

    gadobutrol 604.72 mg/mL

    gadobutrol is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals, LLC. The primary component is GADOBUTROL.

    Product Information

    NDC 70436-0212
    Product ID 70436-212_099b1475-9a8e-2d9a-e063-6294a90a9f8b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name gadobutrol
    Proprietary Name Suffix n/a
    Non-Proprietary Name gadobutrol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 604.72
    Active Ingredient Units mg/mL
    Substance Name GADOBUTROL
    Labeler Name Slate Run Pharmaceuticals, LLC
    Pharmaceutical Class Gadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA217480
    Listing Certified Through 2024-12-31

    Package

    NDC 70436-0212-54 (70436021254)

    NDC Package Code 70436-212-54
    Billing NDC 70436021254
    Package 20 VIAL, SINGLE-DOSE in 1 CARTON (70436-212-54) / 7.5 mL in 1 VIAL, SINGLE-DOSE (70436-212-32)
    Marketing Start Date 2023-10-20
    NDC Exclude Flag N
    Pricing Information N/A